L'objectif général de ce programme de formation est de renforcer la gouvernance de la santé numérique au niveau des pays et la capacité du personnel de santé à mettre en œuvre des stratégies, des architectures, des normes, des infrastructures d'information et des technologies de préparation aux urgences sanitaires nationales et de doter les participants des compétences nécessaires pour adopter

O curso foi concebido para capacitar a liderança dos ministérios com os conceitos técnicos e ferramentas de planeamento necessários para dirigir e orientar as partes interessadas na saúde digital nacional.

नोमा (कैनक्रम ओरिस) मुँह और चेहरे का एक गंभीर अवसाद रोग है, जो मुख्यतः उप सहारा अफ्रीका में 2 से 6 वर्ष के बच्चों को प्रभावित करता है।

पर्याप्त ज्ञान अंतराल के बावजूद, इसे कुपोषण, खराब मौखिक सफाई, प्रतिरक्षादमन, और अत्यधिक गरीबी स्थिति में रहने से जुड़ा बताया गया है।

Noma (cancrum oris) cuta ce mai tsanani ta baki da fuska, wadda ta fi shafar yara masu shekaru 2 zuwa 6 a yankin Saharar Afirka.

Duk da ɗimbin gibin ilimi, an ba da rahoton cewa yana da alaƙa da rashin abinci mai gina jiki, rashin tsaftar baki, hana rigakafi, da rayuwa cikin matsanancin talauci.

Le noma (cancrum oris) est une maladie gangreneuse grave de la bouche et du visage qui touche principalement les enfants âgés de deux à six ans en Afrique subsaharienne.

O noma (cancrum oris) é uma doença gangrenosa grave da boca e da face, afectando principalmente crianças entre os dois e os seis anos na África subsariana.

Este curso aborda considerações sobre epidemiologia, patogénese, características clínicas, diagnóstico, tratamento e saúde pública, incluindo a perspectiva dos direitos humanos no que diz respeito ao noma.

Noma (cancrum oris) is a serious gangrenous disease of the mouth and face, mainly affecting children aged 2 to 6 years in sub-Saharan Africa. Despite substantial knowledge gaps, it is reported to be linked with malnutrition, poor oral hygiene, immunosuppression, and living in extreme poverty situations.

Patients affected by skin conditions present signs and symptoms that guide the next steps for clinicians to reach the correct diagnosis. Sometimes a syndrome is enough to establish a diagnosis while in other instances it is necessary to perform specific tests.

Post-kala-azar dermal leishmaniasis (PKDL) is usually a sequel of visceral leishmaniasis and is one of the skin neglected tropical diseases. It occurs mainly in East Africa and on the Indian subcontinent, where 5–10% of patients with kala-azar are reported to develop the condition. People with PKDL are considered a potential source of Leishmania infection.

Пациенты, подверженные кожным заболеваниям, проявляют признаки и симптомы болезни, которые определяют дальнейшие действия лечащего персонала для постановки правильного диагноза. Иногда для постановки диагноза достаточно одного синдрома, в других случаях требуется провести определенные тесты.